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Rapid induction of apoptosis mediated by peptides that bind
initiation factor eIF4E
Terence P. Herbert*†, Robin Fåhraeus†‡, Alan Prescott‡, David P. Lane‡
and Chris G. Proud*
Overexpression of the translation initiation factor
eIF4E leads to cell transformation and occurs in a
number of human cancers [1]. mRNA translation and
cell growth can be regulated through the availability
of eIF4E to form initiation complexes by binding to
eIF4G. The availability of eIF4E is blocked through
the binding of members of a family of eIF4E-binding
proteins (4E-BPs) [2,3]. Indeed, cell transformation
caused by the overexpression of eIF4E can be
reversed by the overexpression of 4E-BPs [4–8].
To study the role of eIF4E in cell transformation, we
developed a series of peptides based on the
conserved eIF4E-binding motifs in 4E-BPs and eIF4G [9]
linked to the penetratin peptide-carrier sequence,
which mediates the rapid transport of peptides across
cell membranes. Surprisingly, introduction of these
eIF4E-binding peptides into MRC5 cells led to rapid,
dose-dependent cell death, with characteristics of
apoptosis. Single alanine substitutions at key
positions in the peptides impair their binding to
eIF4E and markedly reduce their ability to induce
apoptosis. A triple alanine substitution, which
abolishes binding to eIF4E, renders the peptide unable
to induce apoptosis. Our data provide strong evidence
that the peptides induce apoptosis through binding to
eIF4E. They do not induce apoptosis through inhibition
of protein synthesis, as chemical inhibitors of
translation did not induce apoptosis or affect
peptide-induced cell death. Thus these new data
indicate that eIF4E has a direct role in controlling
cell survival that is not linked to its known role in
mRNA translation.
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Results and discussion
The importance of eIF4E in translational regulation and
cell growth is underscored by observations that overexpres-
sion of eIF4E leads both to increases in protein synthesis
and to cellular transformation in human and mouse cells
[4,5]. The mechanism by which eIF4E overexpression
leads to cell transformation is poorly understood. It is,
however, thought to be through the increased translation of
growth-related mRNAs, which are normally translationally
repressed [1]. To study directly the role of eIF4E in cell
transformation, we developed a series of biotinylated pep-
tides based on the conserved eIF4E-binding motif within
4E-BPs and eIF4G [9] linked to the penetratin peptide
carrier sequence (Figure 1a; peptides BP1 and BP1
YLM–AAA are not biotinylated) [10–12]. The ability of the
biotinylated peptides to bind recombinant human eIF4E
in vitro was assessed by streptavidin–agarose pull-down
assays. The peptides based on the eIF4E-binding site of
human eIF4G, wheat eIF4G or 4E-BP2 (Hu4G, W4G and
BP2) were each able to bind eIF4E in vitro, whereas these
peptides with triple alanine substitutions at conserved
residues and a scrambled peptide could not (Figure 1b, left
panel). Single alanine substitutions at conserved amino-
acid residues within the Hu4G-based peptide led either to
reduction (Hu4G Y–A) or abolition (Hu4G L–A) of their
ability to bind eIF4E in this assay (Figure 1b, left panel).
This pattern of behaviour closely matches our understand-
ing of the molecular basis of the interaction between
eIF4E and its binding protein partners [13]. The Hu4G
peptide also bound eIF4E in cell lysates, whereas the
Hu4G YLL–AAA variant did not (Figure 1b, right panel). 
To investigate the effect of eIF4E-binding peptides in
living cells, 10 m M of the peptide BP2 was incubated with
serum-deprived or serum-fed MRC5 cells. Unexpectedly,
the addition of BP2 to 72 hour serum-starved MRC5 cells
led to rapid cell death (within 1 hour) (Figure 1c, lane 4).
In contrast, serum-fed cells were insensitive to the effect
of BP2 at this concentration (Figure 1c, lane 1). Incubation
of either serum-fed or serum-starved MRC5 cells with the
triple alanine substitution peptide, BP2 YLL–AAA, had no
significant effect on cell viability (Figure 1c, lane 5, and
data not shown). The sensitivity of the cells to the effect of
the peptide increased with the length of time the cells had
been deprived of serum, with maximal effects observed by
72 hours of serum starvation (Figure 1c, lanes 1–4). All
subsequent experiments were therefore performed in cells
deprived of serum for 72 hours. Readdition of 10% serum
for 1 hour to 72 h serum-starved cells protected them from
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the effects of the peptide (Figure 1c, lane 6). This protec-
tive effect could not be inhibited by preincubation of cells
with cycloheximide, a general inhibitor of mRNA transla-
tion (Figure 1c, lane 7). This indicates that serum protects
against peptide-induced cell death through a post-transla-
tional modification rather than by inducing synthesis of
new proteins such as cell-survival proteins. To investigate
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Figure 1
Treatment of cells with eIF4E-binding peptides leads to rapid, dose-
dependent cell death. (a) Sequences of biotinylated, penetratin-linked
peptides in single-letter amino-acid notation. U, norvaline, a
substitution for cysteine. Conserved residues that are important in
binding to eIF4E are underlined. (b) In vitro binding assay. For the left
panel, 1 m g recombinant eIF4E was incubated with 0.2 mM
biotinylated peptides in a total volume of 50 m l wash buffer (1·
PBS/250 mM KCl) for 1 h at 4° C. For the right panel, 0.2 mM Hu4G
or Hu4G YLL–AAA was incubated with 200 m g MRC5 cell lysate for
1 h at 4° C in a total volume of 50 m l wash buffer. In all cases the
biotinylated peptides and associated proteins were pulled down using
streptavidin–agarose. The proteins were separated by SDS–PAGE
and subjected to western blotting using anti-eIF4E antibody. Detection
was by enhanced chemiluminescence. (c–f) Cell survival as a
percentage of control, untreated cells, as measured by MTT (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenylterazolium bromide) assay. (c) 1,
10 m M BP2 peptide added to serum-fed cells; 2–4, 10 m M BP2 added
to 24 h, 48 h or 72 h serum-starved cells, respectively; 5, 10 m M BP2
YLL–AAA added to 72 h serum-starved cells; 6, 72 h serum-starved
cells incubated in 10% serum for 1 h before addition of 10 m M BP2;
7, 72 h serum-starved cells incubated with 100 m g/ml cycloheximide
followed by a 1 h incubation with 10% serum before addition of 10 m M
BP2. In all cases the cells were then incubated for 1 h in 0.1 mg/ml
MTT. Cells were lysed in DMSO and absorbance measured at
570 nm. (d–f) Varying concentrations of peptides were added to 72 h
serum-starved MRC5 cells. After 30 min incubation the cells were then
incubated for 1 h in 0.1 mg/ml MTT. Cells were lysed in DMSO and
absorbance measured at 570 nm. All results are representative of
three separate experiments. (d) Diamonds, BP1; triangles, BP2;
circles, BP1 YLM–AAA; squares, BP2 YLL–AAA. (e) Triangles, Hu4G;
diamonds, Hu4G Y–A; squares, Hu4G YLL–AAA; circles, Hu4G L–A.
(f) Triangles, W4G; squares, W4G YLL–AAA.
Figure 2
Cell death induced by eIF4E-binding peptides shows characteristics
of apoptosis. (a) Time-lapse images of serum-starved MRC5 cells
treated with 10 m M Hu4G peptide for the indicated times. (b) FACS
analysis of MRC5 cells treated with 20 m M Hu4G or Hu4G YLL–AAA
for 40 min. (c) TUNEL analysis using the ‘In situ cell death detection
kit’ (Boehringer Mannheim). MRC5 cells were incubated with 10 m M
Hu4G peptide for 10 min. Cells were visualised with fluorescein by
fluorescence microscopy. No signal was observed in untreated cells
or in cells treated with 10 m M Hu4G YLL–AAA peptide (data not
shown).  Of the cells incubated with 10 m M Hu4G peptide, 80%
fluoresced positive. (d) Images of DAPI-stained MRC5 cells incubated
with either 20 m M Hu4G or Hu4G YLL–AAA peptide for 40 min.
Arrows indicate the position of cells with either a condensed nucleus
(top right) or a nucleus with a punctate appearance (bottom left).
(e) Visualisation of effects of peptides on the MPT. Serum-starved
MRC5 cells were loaded with 0.1 m M JC1 for 30 min before addition
of 10 m M peptide. Changes in mitochondrial permeability were viewed
by laser scanning confocal microscopy (krypton/argon laser) using
identical settings. Green channel, excitation 488 nm/emission 522 nm.
Red channel, excitation 568 nm/emission 585 nm. Channels were
collected separately to avoid crossover. Images were taken 5 min after
addition of peptide.
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further the effect of eIF4E-binding peptides, serum-
starved MRC5 cells were incubated with various concen-
trations of the BP2, BP1, Hu4G and W4G peptides
(Figure 1d–f). Each of these peptides elicited rapid, dose-
dependent cell death (within 30 minutes with 20 m M
peptide, and 1 hour with 10 m M), whereas the addition of
the triple alanine substitution peptides, which are unable
to bind eIF4E, had no significant effect on cell viability
(Figure 1d–f). The single alanine substituted peptide
Hu4G Y–A, which has reduced ability to bind eIF4E
in vitro, also had a reduced capacity to induce cell death
(Figure 1e). Another single alanine substitution peptide,
Hu4G L–A, which was unable to bind eIF4E in vitro, had
a severely reduced ability to induce cell death at concen-
trations up to 10 m M (Figure 1e). At a concentration of
20 m M, however, this peptide could induce cell death,
probably indicating some residual low-affinity binding to
eIF4E not detected in the pull-down assay (Figure 1e). All
peptides that can bind eIF4E in vitro can induce cell
death, even though they have very different sequences
outside their common eIF4E-binding motif (Figure 1a). In
addition, peptides with single or triple alanine substitu-
tions at conserved residues important in binding to eIF4E
either had no significant effect on cell survival or a
reduced ability to induce cell death. Taken together with
the in vitro binding studies, these data underpin a strong
structure–activity relationship and thus provide strong evi-
dence that eIF4E-binding peptides induce cell death
through their interaction with eIF4E.
During cell death induced by eIF4E-binding peptides,
cells shrink and undergo blebbing, two characteristics of
apoptosis (Figure 2a). To investigate whether nuclear con-
densation and DNA cleavage, other characteristics associ-
ated with apoptosis, also occurred, we used a number of
methodologies. FACS analysis of propidium-iodide-stained
MRC5 cells treated with the Hu4G peptide revealed a shift
in the DNA profile from G0/G1 to sub-G0/G1, indicating
cell death and possible chromosomal DNA fragmentation
and/or condensation (Figure 2b). DNA fragmentation was
confirmed using TdT-mediated dUTP nick end labelling
(TUNEL) (Figure 2c). DAPI staining of cell nuclei
revealed that cells incubated with Hu4G presented signs of
nuclear condensation, having either condensed nuclei or
nuclei with a punctate appearance (Figure 2d).
An early event considered decisive in apoptosis is the
opening of the mitochondrial permeability transition
(MPT) pore [14–16]. To characterise further the cell death
induced by eIF4E-binding peptides, the development of
the MPT was investigated in living MRC5 cells loaded
with the fluorescent dye JC1 [15]. No changes in fluores-
cence were observed on addition of the inactive peptide
Hu4G YLL–AAA (Figure 2e). In contrast, addition of
Hu4G led to a rapid increase (within 5 minutes) in the
intensity of the green fluorescence concomitantly with a
loss of orange fluorescence, indicative of a drop in the
mitochondrial transmembrane potential, Y m, within the
mitochondria as a result of MPT pore opening (Figure 2e). 
A conserved family of caspases (aspartic-acid specific cys-
teine proteases) are frequently activated during apoptosis
[17]. No such activation was detected in the cell death
induced by eIF4E-binding peptides (data not shown).
Moreover, pretreatment of the MRC5 cells with
ZVAD.fmk, a wide-spectrum caspase inhibitor, did not
affect peptide-induced cell death (data not shown).
Therefore, the cell death we observed appears not to
involve caspase activation. These data provide evidence
that peptide-induced cell death in MRC5 cells proceeds
through a caspase-independent mechanism that presents
some features of apoptosis. The rapidity with which the
cells die and the apparent lack of caspase activation are
not features associated with classical apoptosis. Caspase
activation is, however, not a prerequisite for apoptosis
[18,19]. It has been reported that apoptosis-inducing factor
(AIF), a protein associated with mitochondria, can induce
rapid caspase-independent apoptosis [20]. Rapid cell
death has also been observed in a number of other cell
types, but not  investigated in detail.
Cell death induced by eIF4E-binding peptides might pos-
sibly be a consequence of a general inhibition of transla-
tion. To study this, serum-starved MRC5 cells were
treated with either cycloheximide or pactamycin, which
inhibit elongation and initiation, respectively. These drugs
essentially abolished protein synthesis (Figure 3a), but had
no effect on cell survival during a 2 hour experiment
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Figure 3
Cell death caused by eIF4E-binding peptide is not mediated through
the role of eIF4E in translation. (a) MRC5 cells starved of serum for 72 h
were treated with 100 m g/ml cycloheximide (Chx), 1 m g/ml pactamycin
(Pact) or 10 m M Hu4G peptide for 2 h before MTT assay. Cells were
pulse labelled with [35S]methionine for 30 min after addition of the
translation inhibitors or peptide. Incorporation of [35S]methionine into
protein was determined following hot trichloroacetic acid precipitation.
Black bars, cell survival; white bars, [35S]methionine incorporation.
(b) MRC5 cells serum starved for 72 h were preincubated with
100 m g/ml cycloheximide or 1 m g/ml pactamycin for 30 min before
addition of 10 m M Hu4G. Cells were then incubated for 1.5 h before
MTT assay. Results are from three independent experiments ( – SEM).
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(Figure 3a), indicating that a block in general translation is
not sufficient to cause cell death over this time period. The
possibility that the peptide-induced cell death involved
upregulation or downregulation of the translation of a spe-
cific mRNA or subset of mRNAs was investigated. MRC5
cells were treated with cycloheximide or pactamycin, to
prevent ongoing protein synthesis, before addition of
Hu4G. This did not, however, result in any protection
against the effect of Hu4G (Figure 3b). Continued transla-
tion is thus not required for the peptides to induce cell
death, and neither is regulation of translation of specific
mRNA(s) involved.
Our data thus indicate that eIF4E has a direct role in con-
trolling cell survival that is not linked to its role in transla-
tion. The mechanism underlying cell death induced by
eIF4E-binding peptide is not clear. Death might be asso-
ciated with a yet undefined function of eIF4E. It has
recently been reported that eIF4E co-localises in the
nucleus with splicing factors, and eIF4E may therefore
have a role in splicing or RNA export [21]. As penetratin-
linked peptides can enter all compartments of the cell,
cell death might be a result of their interference with a
nuclear function of eIF4E. It is also possible that deleteri-
ous perturbations in eIF4E function may directly trigger
the apoptotic machinery. This could be a ‘checkpoint’
mechanism by which the cells sense the integrity of the
translation machinery. Indeed, the rapidity of cell death
suggests that binding of the peptides to eIF4E may
directly signal the induction of cell death. 
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